An overview of ivabradine

An overview of ivabradine

This article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficientl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tumelo Ramoleta, Natalie Schellack, Elmien Bronkhorst
Formato: article
Lenguaje:EN
Publicado: AOSIS 2016
Materias:
ivabradine
if current
sinus node
congestive cardiac failure
angina pectoris
antianginal agent
Medicine
R
Acceso en línea:https://doaj.org/article/61805357e7084c87b3b9155e9a53336a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:61805357e7084c87b3b9155e9a53336a
record_format dspace
spelling oai:doaj.org-article:61805357e7084c87b3b9155e9a53336a2021-11-24T07:44:19ZAn overview of ivabradine2078-61902078-620410.4102/safp.v58i6.4572https://doaj.org/article/61805357e7084c87b3b9155e9a53336a2016-12-01T00:00:00Zhttps://safpj.co.za/index.php/safpj/article/view/4572https://doaj.org/toc/2078-6190https://doaj.org/toc/2078-6204This article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficiently, resulting in the increased use of healthcare resources. Unlike the other antianginal drugs (i.e. the beta-blockers, calcium-channel blockers and organic nitrates), ivabradine specifically targets the If current of the sinus node. It reduces the frequency of angina attacks and increases the time until symptoms during work appear. Clinical evidence has shown that ivabradine is an effective anti-ischaemic and antianginal agent, comparable to the beta-blockers and calcium-channel antagonist in controlling the symptoms of myocardial ischemia.Tumelo RamoletaNatalie SchellackElmien BronkhorstAOSISarticleivabradineif currentsinus nodecongestive cardiac failureangina pectorisantianginal agentMedicineRENSouth African Family Practice, Vol 58, Iss 6, Pp 36-39 (2016)
institution DOAJ
collection DOAJ
language EN
topic ivabradine
if current
sinus node
congestive cardiac failure
angina pectoris
antianginal agent
Medicine
R
spellingShingle ivabradine
if current
sinus node
congestive cardiac failure
angina pectoris
antianginal agent
Medicine
R
Tumelo Ramoleta
Natalie Schellack
Elmien Bronkhorst
An overview of ivabradine
description This article provides an overview of the therapeutic effects of ivabradine in the treatment of coronary artery disease (CAD), and in the management of stable angina pectoris (SAP) and congestive cardiac failure (CCF). Patients with SAP have a reduced quality of life and are unable to work efficiently, resulting in the increased use of healthcare resources. Unlike the other antianginal drugs (i.e. the beta-blockers, calcium-channel blockers and organic nitrates), ivabradine specifically targets the If current of the sinus node. It reduces the frequency of angina attacks and increases the time until symptoms during work appear. Clinical evidence has shown that ivabradine is an effective anti-ischaemic and antianginal agent, comparable to the beta-blockers and calcium-channel antagonist in controlling the symptoms of myocardial ischemia.
format article
author Tumelo Ramoleta
Natalie Schellack
Elmien Bronkhorst
author_facet Tumelo Ramoleta
Natalie Schellack
Elmien Bronkhorst
author_sort Tumelo Ramoleta
title An overview of ivabradine
title_short An overview of ivabradine
title_full An overview of ivabradine
title_fullStr An overview of ivabradine
title_full_unstemmed An overview of ivabradine
title_sort overview of ivabradine
publisher AOSIS
publishDate 2016
url https://doaj.org/article/61805357e7084c87b3b9155e9a53336a
work_keys_str_mv AT tumeloramoleta anoverviewofivabradine
AT natalieschellack anoverviewofivabradine
AT elmienbronkhorst anoverviewofivabradine
AT tumeloramoleta overviewofivabradine
AT natalieschellack overviewofivabradine
AT elmienbronkhorst overviewofivabradine
_version_ 1718415860201160704

Ejemplares similares